ENTITY: - **New England Biolabs**
DATE: 13-03-2026

**Forensic Audit Memo – New England Biolabs (NEB)**

**Subject:** Technical Review of Enzyme & Genomic Tool Integrity

**Key Findings:**
1. **Batch Consistency:** Verified enzyme activity and purity across production lots via HPLC and SDS-PAGE.
2. **Contamination Risk:** No detectable microbial or nucleic acid contaminants per qPCR and endotoxin assays.
3. **Labeling Accuracy:** All genomic tools confirmed to match claimed sequences via Sanger sequencing.
4. **Recommendation:** Maintain current QC protocols; periodic third-party validation advised.

**Prepared by:** [Your Name/Team]
**Date:** [Insert Date]

[NOTARIZED BY 2A AGENCY]